SREBF1 and metabolic dysfunction-associated steatotic liver disease: SCPE inhibited the production of NAFLD by impacting the expression of the liver-X receptor alpha (LXR-α), sterol regulatory element-binding protein 1 (SREBP-1c), and the fatty acid synthase (FAS) gene [38].